Actively Recruiting

Phase Not Applicable
Age: 70Years +
All Genders
ID05526963

Reducing Medication Risks in Elderly People With Multiple Diseases A Stepped Wedge Cluster Randomized Trial Evaluating Medication Review and Adherence Support

Led by Martin-Luther-Universität Halle-Wittenberg · Updated on 2025-01-09

1146

Participants Needed

1

Research Sites

82 weeks

Total Duration

On this page

Sponsors

M

Martin-Luther-Universität Halle-Wittenberg

Lead Sponsor

U

University of Leipzig

Collaborating Sponsor

AI-Summary

What this Trial Is About

Many elderly patients with multiple chronic diseases are treated with five or more medications at the same time, which increases their risk of adverse drug reactions (ADRs). These inappropriate prescriptions can lead to serious problems like falls, hospitalizations, and even death. This study aims to test a new approach to reduce the frequency of ADRs in patients aged 70 years and older who have multiple health conditions and are taking many medications. The study involves a special intervention where patients receive a detailed review of their medications by an external pharmacologist using established criteria to identify potentially inappropriate drugs. This updated medication plan is then given to the patient's family doctor to discuss and implement. In addition, patients receive support from a study nurse through phone calls using motivational interviewing to help improve medication adherence and inform them about the risks of not taking medications properly or signs of side effects. The control group continues with their usual care without these added supports. Participants will be monitored for six months after the intervention to track the rate of adverse drug reactions. Researchers will also assess other factors such as hospitalizations related to medication issues, how well patients stick to their medication plans, quality of life, and the number of inappropriate prescriptions. The study is being conducted across 40 primary care practices in Germany and plans to include 1,146 patients. The goal is to find effective ways to reduce medication-related problems in older adults with multiple health conditions.

CONDITIONS

Official Title

Reduction of Polypharmacy in Elderly People With Multiple Diseases

Who Can Participate

Age: 70Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Taking five or more long-term medications (over 6 months) (polypharmacy)
  • Having three or more chronic diseases (multimorbidity)
  • At least one family doctor consultation within the last 6 months
Not Eligible

You will not qualify if you...

  • Critically reduced life expectancy
  • Unable to visit the family practice independently
  • Unable to participate in the informed consent process
  • Living in a nursing home
  • Diagnosed with dementia or mental/behavioral disorders (ICD-10 F00-F99)
  • Currently participating in another medical study focused on polypharmacy or multimorbidity

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

HAP ANZ

Halle, Saxony-Anhalt, Germany, 06110

Actively Recruiting

Loading map...

Research Team

A

Alexander Bauer, Dr.

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Acutelines: a Large Biobank to Improve Early Recognition and...

Acute Disease

Actively Recruiting

1 location

AdvantAGE: Evaluating a New Interprofessional Transitional C...

Transitional Care

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here